List view / Grid view
Gene testing is a type of medical test that identifies changes in chromosomes, genes, or proteins.
23 April 2015 | By Victoria White
MRC Technology and NYU School of Medicine have signed an agreement to develop an antibody for the prevention of inflammatory osteolysis (bone breakdown)...
21 April 2015 | By Victoria White
Men with prostate cancer benefit from treatment with the pioneering drug olaparib according to the results of a major trial presented today...
8 April 2015 | By Victoria White
Inovio has been selected to receive a grant from DARPA to lead a collaborative team to develop multiple treatment and prevention approaches against Ebola...
30 March 2015 | By Victoria White
Around 6.5 million Europeans currently suffer from AMD. Nanoparticles could potentially be used as carriers for drug treatments instead of injections...
26 March 2015 | By Victoria White
Scientists have revealed a brand new function for one of the first cancer genes ever discovered – the retinoblastoma gene...
26 March 2015 | By Victoria White
New treatments, diagnostics and medical technologies are set to benefit from an investment of £32 million through the Biomedical Catalyst...
9 March 2015 | By Phico Therapeutics
Phico Therapeutics, a biotechnology company developing a novel platform technology for a new generation of antibiotics aimed at overcoming antibacterial resistance, has been awarded a £2.25M Translation Award by the Wellcome Trust to develop its SASPject™ PT4 antibiotic, aimed at Escherichia coli and Klebsiella pneumoniae...
4 March 2015 | By The Institute of Cancer Research
Testing breast cancer cells for how closely they resemble stem cells could identify women with the most aggressive disease, a new study suggests...
4 February 2015 | By Frost & Sullivan
Ongoing research aims to develop oncologic imaging technologies that diagnose cancer at the cellular level before the disease manifests, finds Frost & Sullivan...
3 February 2015 | By Motif Bio
Motif Bio plc is seeking to raise at least £4 million through a placing of new ordinary shares and admission to trading on AIM...
12 January 2015 | By Roche
Collaboration leverages both companies’ strengths to advance the progress of personalized treatments for patients with cancer...
15 December 2014 | By The Institute of Cancer Research, London, and Cancer Research UK Manchester Institute
A brand new family of cancer drugs designed to block several key cancer-causing proteins at once could potentially treat incurable skin cancers, a major new study reports...
1 December 2014 | By ABIVAX
ABIVAX, a leading clinical stage biotech company developing and commercialising anti-viral compounds and human vaccines, announced the successful completion of its Phase 1 first-in-man study of ABX464, which has been designed to potentially deliver a number of important clinical benefits when treating patients with HIV.,,
12 November 2014 | By New Oncology
New Oncology announced that it has entered into a collaboration with the National Cancer Centre Singapore (NCCS)...
14 October 2014 | By New Oncology
New Oncology announced that it has entered into a collaboration agreement with Gustave Roussy Cancer Campus, Paris...
